Holen Sie sich die Stockscreener-App
67.03
1.41%
0.9051
Schlusskurs vom Vortag:
$66.12
Offen:
$66.74
24-Stunden-Volumen:
1.03M
Relative Volume:
0.95
Marktkapitalisierung:
$11.63B
Einnahmen:
$8.35B
Nettoeinkommen (Verlust:
$1.56B
KGV:
7.5531
EPS:
8.8738
Netto-Cashflow:
$-4.00M
1W Leistung:
-3.40%
1M Leistung:
-11.25%
6M Leistung:
-8.64%
1J Leistung:
-7.26%
1-Tages-Spanne:
$66.17
$67.37
1-Wochen-Bereich:
$65.65
$68.84
52-Wochen-Spanne:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Compare SOLV vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
67.05 | 11.47B | 8.35B | 1.56B | -4.00M | 8.8738 |
|
ISRG
Intuitive Surgical Inc
|
473.88 | 170.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
160.46 | 45.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.16 | 38.26B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
231.69 | 33.86B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.25 | 33.33B | 28.43B | 1.16B | 1.26B | 1.4457 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Barclays PLC Decreases Stock Holdings in Solventum Corporation $SOLV - MarketBeat
Top Solventum Insider Quietly Makes a Major Bullish Move - TipRanks
Investor Takes $14 Million Position in WEX as Fintech Firm Generates Record $2.7 Billion in Revenue - The Motley Fool
Solventum to Participate in the 2026 KeyBanc Healthcare Forum - PR Newswire
Insider Buying: Solventum (NYSE:SOLV) Director Buys 1,475 Shares of Stock - MarketBeat
Wendell Amy McBride buys Solventum (SOLV) shares worth $100k By Investing.com - Investing.com Nigeria
Wendell Amy McBride buys Solventum (SOLV) shares worth $100k - Investing.com
Intech Investment Management LLC Has $633,000 Stock Holdings in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation (NYSE:SOLV) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Will Solventum's (SOLV) Strong Q4, 2026 Outlook and Buyback Shift Its Capital Allocation Narrative - Sahm
JBC Technologies Named Solventum Premier Converter at MD&M West - Medical Device and Diagnostic industry
Solventum (NYSE: SOLV) CEO logs 105,963 RSU grant and tax share disposal - Stock Titan
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
Solventum’s Post-Spin Discount Looks Big, But Growth Must Show Up - Finimize
Solventum (NYSE:SOLV) Cut to Hold at Wall Street Zen - MarketBeat
A Look At Solventum (SOLV) Valuation After Q4 2025 Earnings Beat And 2026 Outlook Update - simplywall.st
Solventum Corp. stock falls Tuesday, underperforms market - MSN
The Turnaround Titan Leads Solventum to Success - Medical Device and Diagnostic industry
Solventum outlines 2026 organic sales growth of 2%-3% while advancing portfolio optimization and margin expansion - MSN
Solventum (SOLV) Q4 2025 adjusted diluted EPS reaches $1.57 on 3.5% organic sales growth - MSN
Solventum (SOLV) Q4 2025 Adjusted Diluted EPS Reaches $1.57 on 3.5% Organic Sales Growth - Finviz
Solventum (SOLV) is Among the Highest-Rated Value Stocks: Is It Worth Purchasing? - Bitget
SOLV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Commit To Purchase Solventum At $65, Earn 11.6% Annualized Using Options - Nasdaq
Solventum : Shareholder Letter Q4 2025 - marketscreener.com
Solventum Stock: Improvements Come Slow (NYSE:SOLV) - Seeking Alpha
UBS Adjusts Solventum Price Target to $82 From $79, Maintains Neutral Rating - marketscreener.com
Solventum’s High-Stakes Restructuring: Profitability Ambitions Face Significant Execution Risks - The Globe and Mail
Solventum Corporation (SOLV) Stock Analysis: A 21% Upside Potential Amidst Mixed Signals - DirectorsTalk Interviews
Solventum Corporation $SOLV Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Will Solventum's (SOLV) $1 Billion Buyback and Strong 2025 Earnings Redefine Its Capital Story? - Sahm
Solventum Earnings Call Balances Growth With Headwinds - TipRanks
Solventum Sets Confident Course with Strategic Overhaul and 2026 Guidance - AD HOC NEWS
SOLV PE Ratio & Valuation, Is SOLV Overvalued - Intellectia AI
A Look At Solventum (SOLV) Valuation After Earnings Beat Buyback Plan And Growth Guidance - Yahoo Finance
Citigroup Inc. Decreases Holdings in Solventum Corporation $SOLV - MarketBeat
Andra AP fonden Has $8.04 Million Holdings in Solventum Corporation $SOLV - MarketBeat
Solventum Q4 Earnings Call Highlights - MarketBeat
Is It Time To Reassess Solventum (SOLV) After The 3M Separation? - simplywall.st
US Bancorp DE Has $31.04 Million Stock Position in Solventum Corporation $SOLV - MarketBeat
Solventum (NYSE:SOLV) Rating Increased to Buy at Wall Street Zen - MarketBeat
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know - The Globe and Mail
Piper Sandler reiterates Solventum stock rating on revenue growth By Investing.com - Investing.com South Africa
Solventum Q4 FY25 slides: organic growth solid despite earnings miss By Investing.com - Investing.com Australia
Solventum (SOLV) One Off US$1.5b Gain Raises Questions For Bullish Margin Narratives - simplywall.st
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
SOLV: BTIG Reiterates 'Buy' Rating with Price Target Unchanged a - GuruFocus
Solventum Dental Solutions Sales Grow 8.6% in Q4 - Orthodontic Products
Solventum Corp SEC 10-K Report - TradingView
Solventum (NYSE:SOLV) Given New $83.00 Price Target at Wells Fargo & Company - MarketBeat
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down - Yahoo Finance
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.01%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):